No increased risk of serious cardiovascular events among adults who use ADHD medications: study

December 12, 2011

Although there have been cardiovascular safety concerns about attention-deficit/hyperactivity disorder (ADHD) medications because of their ability to increase heart rate and blood pressure levels, an analysis that included more than 150,000 ADHD users found no evidence of an increased risk of heart attack, stroke or sudden cardiac death associated with current use compared with nonuse or rare use among young and middle-aged adults, according to a study appearing in JAMA. The study is being released early online because of its public health importance.

"Between 2001 and 2010, use of medications labeled for treatment of ADHD increased even more rapidly in adults than in children. According to a 2006 U.S. (FDA) advisory committee briefing on the safety of ADHD medications, more than 1.5 million U.S. adults were taking stimulants in 2005, and adults received approximately 32 percent of all issued prescriptions," according to background information in the article. "Placebo-controlled studies in children and adults indicate that stimulants and atomoxetine [a medication used to treat ADHD] elevate levels by approximately 2 to 5 mm Hg and diastolic by 1 to 3 mm Hg and also lead to increases in . Although these effects would be expected to slightly increase risk for [MI; ], (SCD), and stroke, clinical trials have not been large enough to assess risk of these events."

Laurel A. Habel, Ph.D., of Kaiser Permanente Northern California, Oakland, and colleagues examined whether medications used primarily to treat ADHD are associated with an increased , SCD, or stroke in adults. The researchers used computerized from 4 study sites, starting in 1986 at 1 site and ending in 2005 at all sites, with an additional assessment using 2007 survey data. Participants were adults 25 through 64 years of age with dispensed prescriptions for methylphenidate, amphetamine, or atomoxetine. Each medication user (n = 150,359) was matched to two nonusers on study site, birth year, sex, and calendar year (total users and nonusers = 443,198).

During follow-up, there were 1,357 cases of heart attacks, 296 cases of sudden , and 575 cases of stroke. After analyses of the data, the researchers found that current or new use of ADHD medications, compared with nonuse or remote use, was not associated with an increased risk of serious , such as heart attack, sudden cardiac death, or stroke. "We also found little support for an increased risk for any specific medication or with longer duration of current use. Results were similar when users were restricted to new users. Rate ratios did not appear to be influenced by prior cardiovascular disease or by prior non-ADHD psychiatric conditions. They also were similar across age groups. As expected, event rates were substantially higher in the Medicaid population; however, the rate ratio for current use was similar to that in other sites," the authors write.

The researchers also found that among ever users of ADHD medications, the adjusted rate ratio of serious cardiovascular events was nearly the same during periods of current use as during follow-up periods more than 1 year after use ended. Cardiovascular diseases were similar or slightly more prevalent in new users than nonusers.

The authors note that a modestly elevated risk of serious cardiovascular events cannot be ruled out, given limited power of the study and a lack of complete information on some potentially important risk factors and other factors related to use of these medications.

In an accompanying editorial, Philip Shaw, M.D., Ph.D., formerly of the National Institute of Mental Health (currently with the Human Genome Research Institute), Bethesda, Md., writes that the findings of this study raise several clinically important issues.

"First, the findings support the final decision by the FDA in 2006 not to place a black box warning of serious cardiovascular events on ADHD medications for all children and adults but to pursue further research. The findings, however, do not directly inform the current black box warning for psychostimulants, which is confined to patients with structural heart lesions. The study focused on very rare events, which prevented examination of specific subgroups such as individuals with cardiac disease. Joint care by cardiologists and other physicians remains necessary for these individuals. In addition, the study provides no evidence to support routine obtaining of electrocardiograms before starting treatment, certainly insofar as this recommendation was driven by concerns about serious cardiovascular events."

Explore further: No increase in severe cardiovascular events for children, adolescents taking ADHD medications

More information: DOI:10.1001/JAMA.2001.1830 , DOI:10.1001/JAMA.2011.1866

Related Stories

No increase in severe cardiovascular events for children, adolescents taking ADHD medications

May 16, 2011
Despite recent concerns that medications for attention deficit hyperactivity disorder (ADHD) could increase the risk of cardiovascular events in children and adolescents, an observational study conducted by researchers at ...

No heart attack risk from attention-deficit drugs: study

November 1, 2011
A major study of more than one million children and young adults has shown no higher risk of heart attack among those who take drugs for attention deficit hyperactivity disorder, a US study said Tuesday.

Millions with peripheral artery disease not getting vital medications

June 20, 2011
Millions of adults with peripheral artery disease are not receiving the medications needed to reduce their risk of heart attack, stroke and death, according to research in Circulation: Journal of the American Heart Association.

Recommended for you

ADHD medication tied to lower risk for alcohol, drug abuse in teens and adults

July 13, 2017
The use of medication to treat attention deficient hyperactivity disorder is linked to significantly lower risk for substance use problems in adolescents and adults with ADHD, according to a study led by researchers at Indiana ...

Video game promotes better attention skills in some children with sensory processing dysfunction

April 6, 2017
A video game under development as a medical device boosts attention in some children with sensory processing dysfunction, or SPD, a condition that can make the sound of a vacuum, or contact with a clothing tag intolerable ...

Children with ADHD often live in chaotic households

March 9, 2017
Researchers often observe inadequate parenting, a negative emotional climate and household chaos in families of children with ADHD. A research group at Goethe University Frankfurt and the universities of Bremen, Heidelberg, ...

ADHD a 'brain disorder', not just bad behaviour: study

February 16, 2017
People with ADHD have slightly smaller brains than those without the condition, according to a study released Thursday which insisted it is a physical disorder and not just bad behaviour.

Could the 'Mediterranean' diet help prevent ADHD?

January 30, 2017
(HealthDay)—Kids who follow a Mediterranean diet—high in fruits, vegetables and "good" fats—may be less likely to have attention deficit hyperactivity disorder (ADHD), a small study suggests.

Data scientists find causal relation in characteristics of ADHD

December 2, 2016
Hyperactivity seems to be the result of not being able to focus one's attention rather than the other way around. This was proposed in an article in PLOS ONE, written by researchers at Radboud university medical center and ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.